Search results
4 questions to ask before your CD matures
CBS News· 6 days agoIt's important to know the answers to these questions as you approach your CD account maturity date.
I’m a Bank Teller: 4 Reasons You Should Withdraw Your Savings Right Now
GOBankingRates via Yahoo Finance· 2 days agoRoughly 95% of Americans have either a checking or savings account, according to the Federal Deposit...
CDs vs. Stocks: What Should You Invest in Now?
The Motley Fool· 1 day agoWhen you're looking to invest, the returns stocks can offer can be appealing, but so can the steady nature of CDs. Which is best right now? Find out here.
I just tested JBL's new retro-style speaker — and the sound is stunning
Tom's Guide via Yahoo News· 3 days agoThe depth and the weight of the extraordinary vocal is surprisingly convincing, and despite being a...
What is Hi-Res Audio? Lossless music explained (and how to get it)
TechRadar· 5 days agoIf you've been in the market for a set of the best headphones, the best stereo speakers, the best...
Rewind: our final verdict on the LG G4 OLED TV, Chord Ultima Integrated amplifier and more
What Hi-Fi? via Yahoo News· 15 hours agoThis is awesome, especially for those like us that love separates, but it can make getting the right...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 5 days agoThe drugs have the potential to replace revenues...AbbVie’s portfolio across IBD. IBD also includes...
Ask an Advisor: I'm 61. I Have $800k Sitting in a Money Market Account. How Should I Invest?
SmartAsset via Yahoo Finance· 1 day agoI have $800,000 sitting in a money market account because I don't know what else to do with it. My...
Colorado Democrats elevate divisive GOP candidate in race for Boebert seat
The Hill via Yahoo News· 1 day agoDemocrats are looking to elevate a controversial candidate in the GOP primary for a House seat set...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 6 days agoSkyrizi’s approval for the UC indication was based on data from two phase III studies, a 12-week induction study, INSPIRE1 and a 52-week maintenance study, COMMAND2. Skyrizi is already approved ...